Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology

Advanced search

Section Details


ORIGINAL ARTICLES

 
Issue Title
 
Vol 14, No 3 (2021) Pharmacoeconomic evaluation of the effectiveness of therapy for metastatic colorectal cancer Abstract   PDF (Rus)
Yu. Yu. Petukhova, E. V. Eliseeva, M. V. Volkov, O. N. Li, A. G. Petukhova
 
Vol 14, No 3 (2021) Peculiarities of administration of medications to patients with circulatory system diseases within the framework of the federal program of preferential provision of medicines Abstract   PDF (Rus)
I. K. Petrukhina, R. I. Yagudina, N. V. Veyner, T. K. Ryazanova, E. P. Gladunova, V. A. Kurkin, P. R. Blinkova, E. N. Zaitseva
 
Vol 14, No 3 (2021) Increasing the medico-economic efficiency of preventive counseling for patients with arterial hypertension and behavioral risk factors for non-communicable diseases Abstract   PDF (Rus)
O. L. Zadvornaya, A. N. Pishchita
 
Vol 14, No 3 (2021) Pharmacoeconomic features of drug provision to the rheumatology department of the republican clinical hospital Abstract   PDF (Rus)
L. N. Sheikhmambetova, E. A. Egorova, K. N. Onishchenko, E. I. Konyaeva
 
Vol 14, No 3 (2021) Pharmacoeconomic analysis of the application of strong opioids for the treatment of chronic pain syndrome in patients with pancreatic cancer Abstract   PDF (Rus)
O. P. Bobrova, S. K. Zyryanov, N. A. Shnayder, M. M. Petrova
 
Vol 14, No 3 (2021) COVID-19 pandemic prediction model based on machine learning in selected regions of the Russian Federation Abstract   PDF (Rus)
D. V. Gavrilov, R. V. Abramov, А. V. Kirilkina, А. А. Ivshin, R. E. Novitskiy
 
Vol 14, No 2 (2021) Chemoreactome screening of pharmaceutical effects on SARS-CoV-2 and human virome to help decide on drug-based COVID-19 therapy Abstract   PDF (Rus)
I. Yu. Torshin, O. A. Gromova, A. G. Chuchalin, Yu. I. Zhuravlev
 
Vol 14, No 2 (2021) Impact of disease information (Ebola and COVID-19) on the pharmaceutical sector in Russia and USA Abstract   PDF (Rus)
E. A. Fedorova, D. O. Afanasyev, A. V. Sokolov, M. P. Lazarev
 
Vol 14, No 2 (2021) Survey-based evaluation of the awareness of pharmaceutical specialists on the pharmacotherapy of climacteric syndrome Abstract   PDF (Rus)
M. A. Chernyavskaya, I. A. Narkevich
 
Vol 14, No 2 (2021) Organizational and economic aspects of triplet therapy of relapsed/refractory multiple myeloma in the Russian healthcare setting Abstract   PDF (Rus)
E. A. Pyadushkina, E. V. Derkach, V. I. Ignatyeva, E. E. Yagnenkova, T. Yu. Klitochenko, T. V. Shelekhova, A. N. Levanov
 
Vol 14, No 2 (2021) Medical care payment improvement within diagnosis-related groups of patients with severe asthma requiring biologic disease-modifying drugs by regional adaptation mechanism in the Moscow Region Abstract   PDF (Rus)
A. D. Ermolaeva, V. S. Krysanova, T. N. Ermolaeva, K. I. Polyakova, K. A. Kokushkin
 
Vol 14, No 2 (2021) Analysis of the availability and affordability of pharmaceuticals for children in need of palliative care Abstract   PDF (Rus)
D. M. Medvedeva, I. A. Narkevich, O. D. Nemyatykh
 
Vol 14, No 2 (2021) Effect of vitamin D intake on quality of life parameters in office workers Abstract   PDF (Rus)
A. T. Sharman, Sh. K. Adambekov, A. A. Imandosova, G. F. Elemesova
 
Vol 14, No 2 (2021) Pharmacoeconomic aspects of oral vinorelbine application: a budget impact analysis considering the new registered price Abstract   PDF (Rus)
D. A. Ivanov, I. N. Dyakov, S. K. Zyryanov
 
Vol 14, No 2 (2021) Pharmacoeconomic aspects of the therapy for moderate and severe psoriatic arthritis Abstract   PDF (Rus)
A. V. Rudakova, D. G. Tolkacheva, V. D. Sokolova
 
Vol 14, No 2 (2021) Clinical and economic analysis of using the thrombodynamics test in patients undergoing treatment with assisted reproductive technologies in the Russian Federation Abstract   PDF (Rus)
D. G. Shchurov, V. S. Dombrovskiy
 
Vol 14, No 3 (2021) Health economic evaluation of risdiplam in patients with spinal muscular atrophy Abstract   PDF (Rus)
А. S. Kolbin, А. А. Kurylev, Yu. Е. Balykina, М. А. Proskurin, S. А. Mishinova
 
Vol 14, No 1 (2021) Perspectives of osteoarthritis prevention and therapy personification based on the analysis of comorbid background, genetic polymorphisms and microelement status Abstract   PDF (Rus)
I. Yu. Torshin, A. M. Lila, A. V. Naumov, I. S. Sardaryan, T. E. Bogacheva, T. R. Grishina, I. V. Gogoleva, O. A. Limanova, O. A. Gromova
 
Vol 14, No 1 (2021) Analysis of acquisition and the monthly cost of antihypertensive therapy with modern fixed-dose combinations in the Far Eastern Federal District Abstract   PDF (Rus)
M. S. Soboleva, E. E. Loskutova
 
Vol 14, No 1 (2021) Differences in the standardization of medicinal products based on extracts of chondroitin sulfate Abstract   PDF (Rus)
O. A. Gromova, I. Yu. Torshin, B. Ts. Zaychik, E. V. Shikh, A. O. Ruzhitskiy, A. N. Galustyan, I. S. Sardaryan, I. V. Sarvilina
 
Vol 14, No 1 (2021) Development of a method for the analysis of the lists of medicines and its application for the analysis of the lists of medicines in Russia, England, and Italy Abstract   PDF (Rus)
V. A. Lemeshko, K. I. Matrenin, V. V. Omelyanovskiy, Yu. V. Vasilyeva, G. R. Khachatryan, L. A. Kolganov
 
Vol 14, No 1 (2021) Clinical and economic constituents of the application of dexamethasone and tocilizumab in the therapy for severe conditions in patients with COVID-19 Abstract   PDF (Rus)
O. V. Zhukova, A. L. Khokhlov
 
Vol 13, No 4 (2020) Meta-analysis of clinical trials of osteoarthritis treatment effectiveness with Chondroguard Abstract   PDF (Rus)
I. Yu. Torshin, A. M. Lila, A. V. Naumov, A. Yu. Kochish, L. I. Alekseeva, E. A. Taskina, I. V. Sarvilina, A. N. Galustyan, A. N. Gromov, A. K. Khadzhidis, L. V. Vasilieva, E. F. Yevstratova, M. I. Udovika, O. A. Gromova
 
Vol 13, No 4 (2020) Regional aspects for assessing the effectiveness of resources management in medical organizations Abstract   PDF (Rus)
О. A. Volkova, E. V. Smirnova, S. N. Cherkasov
 
Vol 13, No 4 (2020) Pharmacoeconomic feasibility of using the drug Hemangiol (propranolol, oral solution) in the treatment of proliferating infantile hemangioma requiring systemic therapy Abstract   PDF (Rus)
I. N. Dyakov, S. R. Varfolomeеva
 
Vol 13, No 4 (2020) Peptides contained in the composition of Laennec that contribute to the treatment of hyperferritinemia and iron overload disorders Abstract   PDF (Rus)
O. A. Gromova, I. Yu. Torshin, V. A. Maksimov, A. G. Chuchalin, V. G. Zgoda, А. N. Gromov, O. V. Tikhonova
 
Vol 13, No 4 (2020) Pharmacoeconomic analysis of first-choice antimicrobial drugs prescribed for outpatient treatment of non-severe community-acquired pneumonia Abstract   PDF (Rus)
V. G. Deriushkin, A. P. Ternavskii, S. V. Gatsura
 
Vol 13, No 4 (2020) The social-economic burden of spinal muscular atrophy in Russia Abstract   PDF (Rus)
A. S. Kolbin, D. V. Vlodavets, A. A. Kurylev, Yu. Ye. Balykina, M. A. Proskurin, S. A. Mishinova, O. Yu. Germanenko, N. Yu. Kolbina
 
Vol 13, No 4 (2020) Evaluation of the reference value of the incremental parameter "cost-effectiveness" for Russian healthcare system Abstract   PDF (Rus)
T. S. Teptsova, N. Z. Musina, V. V. Omelyanovsky
 
Vol 13, No 4 (2020) Evaluation of the economic effect of biological therapy in patients with severe COVID-19 and cytokine storm Abstract   PDF (Rus)
M. Yu. Frolov, A. S. Salasyuk, V. A. Rogov
 
Vol 13, No 3 (2020) Evaluation of the antitumor drugs therapeutic value using the method of multicriterial analysis of decision-making Abstract   PDF (Rus)
V. A. Lemeshko, N. Z. Musina, V. V. Omelyanovskiy
 
Vol 13, No 3 (2020) Chemomicrobiomic analysis of glucosamine sulfate, prebiotics and non-steroidal anti-inflammatory drugs Abstract   PDF (Rus)
O. A. Gromova, I. Yu. Torshin, A. V. Naumov, V. A. Maksimov
 
Vol 13, No 3 (2020) The evaluation of the balance of standard rates within the program on state guarantees to deliver free medical care to the citizens of the Russian Federation Abstract   PDF (Rus)
D. V. Fedyaev, S. A. Kovaleva, K. V. Gerasimova
 
Vol 13, No 3 (2020) Parameters for evaluating the main indicators of coloproctological care in the adult population in the subjects of the far Eastern Federal District in 2016–2018 Abstract   PDF (Rus)
A. V. Veselov, V. V. Omelyanosvkiy, Yu. A. Shelygin, A. V. Vitko, V. N. Kashnikov, N. V. Tashkinov, T. V. Shkurko, A. I. Moskalev, A. A. Serbina
 
Vol 13, No 3 (2020) Comparative analysis of antipsychotic drug consumption for inpatient schizophrenia treatment: a retrospective study with 5-year follow-up Abstract   PDF (Rus)
L. B. Vaskova, M. V. Tiapkina, E. V. Mikhaylenko
 
Vol 13, No 3 (2020) The use of various genetically engineered biological drugs and selective immunosuppressants within the current provider-payment model of russian diagnosis-related groups Abstract   PDF (Rus)
E. V. Derkach, E. A. Pyadushkina, M. V. Avxentyeva, T. V. Boyarskaya, E. E. Yagnenkova, A. S. Mokrova, M. M. Maryanyan
 
Vol 13, No 2 (2020) Prognosis of the influence of direct oral anticoagulants on the direct medical expenses in patients with atrial fibrillation Abstract   PDF (Rus)
S. V. Malchikova, A. N. Korobeinikova, N. S. Maksimchuk-Kolobova, M. V. Kazakovtseva
 
Vol 13, No 2 (2020) COVID-19 pandemic: protective role of vitamin D Abstract   PDF (Rus)
O. A. Gromova, I. Yu. Torshin, G. Kh. Gabdulina
 
Vol 13, No 2 (2020) Analysis of 19.9 million publications from the PubMed/MEDLINE database using artificial intelligence methods: approaches to the generalizations of accumulated data and the phenomenon of “fake news Abstract   PDF (Rus)
I. Yu. Torshin, O. A. Gromova, L. V. Stakhovskaya, N. P. Vanchakova, A. N. Galustyan, Zh. D. Kobalava, T. R. Grishina, A. N. Gromov, I. A. Ilovaiskaya, V. M. Kodentsova, A. G. Kalacheva, O. A. Limanova, V. A. Maksimov, S. I. Malyavskaya, E. V. Mozgovaya, N. I. Tapilskaya, K. V. Rudakov, V. A. Semenov
 
Vol 13, No 2 (2020) Biological effects of phytoestrogens: clinical effectiveness and potential application in the treatment of climacteric syndrome Abstract   PDF (Rus)
M. A. Chernyavskaya, I. A. Narkevich
 
Vol 13, No 2 (2020) Pharmacoeconomic analysis of tiotropium bromide and olodaterol fixed combination as maintenance therapy for patients with COPD in the Russian Federation Abstract   PDF (Rus)
S. V. Nedogoda, M. Yu. Frolov, A. S. Salasyuk, I. N. Barykina, V. O. Smirnova
 
Vol 13, No 2 (2020) Improvements to the formation of lists of drugs for medical use: analysis of changes in the Government Decree no. 871 Abstract   PDF (Rus)
V. V. Omelyanovskiy, E. A. Maksimkina, O. I. Ivakhnenko, M. V. Avxentyeva, M. V. Sura, G. R. Khachatryan
 
Vol 12, No 4 (2019) Comparative clinical and economic analysis of using SYSADOA drugs containing chondroitin sulphate or influencing its biosynthesis in the treatment of patients with stage II knee osteoarthritis Abstract   PDF (Rus)
I. V. Sarvilina, A. N. Galustyan, A. K. Hadzhidis, I. S. Sardaryan, N. V. Lavrov, O. A. Gromova, Yu. S. Prokofieva
 
Vol 12, No 4 (2019) Pharmacoeconomic analysis of using biological agents for uncontrolled moderate-to-severe atopic asthma in the Russian Federation Abstract   PDF (Rus)
S. K. Zyryanov, I. N. Diyakov, S. N. Avdeev
 
Vol 12, No 4 (2019) Pharmacoeconomic analysis of using cyclin-dependent kinase 4 and 6 inhibitors in the first line treatment of HR-positive HER2-negative advanced breast cancer Abstract   PDF (Rus)
N. A. Avxentyev, E. V. Lubennikova, M. Yu. Frolov
 
Vol 12, No 4 (2019) Clinical and economic analysis of drug costs in a general hospital in 2014-2018 Abstract   PDF (Rus)
A. T. Burbello, A. S. Fedorenko, E. L. Latariya, M. V. Pokladova, K. A. Zagorodnikova
 
Vol 12, No 4 (2019) Optimization of drug supply for patients with malignant neoplasms in a region of the Russian Federation Abstract   PDF (Rus)
A. V. Nikitina, F. V. Gorkavenko, Y. S. Saybel, M. V. Avxentyeva, M. S. Sura, D. V. Fedyaev
 
Vol 12, No 4 (2019) Crucial areas of the economic analysis of public cancer care Abstract   PDF (Rus)
D. A. Andreev, K. I. Polyakova, A. A. Zavyalov, T. N. Ermolaeva, A. G. Fisun, A. D. Ermolaeva, V. A. Dubovtseva, T. E. Maksimova
 
Vol 12, No 2 (2019) Comparative modeling of socio-economic burden among smokers, nonsmokers and former smokers Abstract   PDF (Rus)
E. V. Radchenko, A. S. Kolbin
 
Vol 12, No 2 (2019) Pharmacoeconomic analysis of ceftazidime+avibactam (Zavicefta®) in the treatment of sepsis caused by carbapenem-resistant enterobacteria Abstract   PDF (Rus)
S. V. Nedogoda, A. S. Salasyuk, I. N. Barykina, V. O. Smirnova
 
1 - 50 of 51 Items 1 2 > >>